June 2015

Blood that has been made in a laboratory will be tested by the NHS within two years. The new blood cells will be made in bulk from stem cells that normally circulate in the blood. Around 20 people will be given small quantities of the “lab-blood” as part of safety tests. NHS Blood and Transplant said it […]

Read More

Weak oversight is allowing lab failures to put patients at risk, article says. An investigation by the Milwaukee Journal Sentinel determined that many U.S. laboratories aren’t following basic protocols to ensure accurate test results, putting patient health at risk. Anywhere from 7 billion to 10 billion lab tests are conducted in the United States annually. Medical decisions are […]

Read More

The FDA cleared Nova Biomedical’s StatStrip Xpress Glucose Hospital Meter System for use throughout all hospital and all professional health care settings, including patients in the intensive care unit. StatStrip Glucose and StatStrip Xpress Glucose are now the only two hospital blood glucose meters to be cleared by the FDA for use with critically ill patients. Use […]

Read More

Rosetta Genomics has announced the commercial launch of OncoGxOne, Admera Health’s next-generation sequencing panel that detects genetic alterations implicated in cancer to provide clear, concise, and actionable clinical recommendations from a single test. Rosetta said OncoGxOne interrogates all types of genomic aberrations in 64 genes, specifically 56 related to cancer targeted therapy and eight related […]

Read More